HUMAN VACCINES

Mission

The Human Vaccines Committee works together to increase global access to critical live attenuated, protein-based, conjugated polysaccharide, and genetically based vaccines by encouraging science-based solutions and supporting access to venues where scientists can meet and discuss challenges and potential opportunities for global alignment.

Goals & Objectives

Enhance the quality and availability of vaccines for personal health, local diseases, and global pandemics.

Provide timely forums for presentation of science and regulatory development of vaccines, as well as new and evolving technologies and development approaches.

Engage global leaders in academia, industry, and regulatory bodies to facilitate standardization of regulatory science principles and practices in vaccines.

Encourage innovation in science and regulation through engagement and collaboration among vaccines experts.

Members

Pieter NEELS
Chair

Steve BLACK
Cincinnati Children’s Hospital

Ananda BANDYOPADHYAY
BMGF

Giuseppe DEL-GIUDICE
GSK

Bernard FRITZELL
Affiliation

Nathalie GARCON
Bioaster

Elwyn GRIFFITHS
IABS

Paul-Henri LAMBERT
University of Geneva

Laurent MALLET
EDQM

Marc VAN OOIJ
J&J

Volker OEPPLING
PEI

Jeff ROBERTS
Merck

Rebecca SHEETS
IABS

Franck VANDENDRIESSCHE
IABS

Priorities & Initiatives

Conferences and Workshop planning

To review IABS Human Vaccines committee and workshops, click on the button below.